We found the median expression of CXCR4 to be significantly higher in breast tumours, in both primary and metastatic carcinomas, than in normal mammary tissue (P=0.0027 and 0.016, respectively) (Figure 4A). Here, CXCR4 is linked to metastatic carcinoma.